REBLOZYL® (luspatercept-aamt) for the Treatment of Anaemia Associated with Beta-Thalassemia
REBLOZYL® (luspatercept-aamt) is administered through a subcutaneous injection with a starting dose of 1mg/kg. Credit: Celgene Corporation.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
-
SWIL Systems
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video...
About
ZUMEDU, created by SWIL Systems, provides cloud-based, end-to-end encrypted video conference solutions for clinical researchers, including contract research organisations (CROs), sponsors and institutions.
FollowMake an Enquiry
